Medpace Holdings (MEDP) Other financing activities (2015 - 2026)
Medpace Holdings' (MEDP) quarterly Other financing activities came in at $6.4 million in Q2 2026, up 1730.2% on a YoY basis from $351000.0 in Q2 2025, and down 49.3% quarter-over-quarter from $12.7 million in Q1 2026.
Analysis
Medpace Holdings (MEDP) Other financing activities (2015 - 2026) Analysis & Trends
Medpace Holdings (MEDP) has reported Other financing activities for 12 consecutive years, with $6.4 million the latest figure, recorded in Q2 2026.
- For the quarter ending Q2 2026, Other financing activities rose 1730.2% year-over-year to $6.4 million; the trailing twelve-month figure through Jun 2026 stood at $49.8 million (up 47.29% YoY), and the FY2025 full-year result was $57.0 million, up 259.45% from the prior year.
- Other financing activities fell to $6.4 million in Q2 2026 per MEDP's latest filing, from $12.7 million in the prior quarter.
- Across five years, Other financing activities topped out at $25.9 million in Q1 2025 and bottomed at $351000.0 in Q2 2025.
- Historically, Other financing activities has averaged $7.0 million across 5 years, with a median of $5.7 million in 2022.
- The sharpest annual moves came in 2023 and 2026: Other financing activities tumbled 82.24% in 2023, then jumped 1730.2% in 2026.
- Over 5 years, Other financing activities stood at $5.8 million in 2022, then tumbled by 73.56% to $1.5 million in 2023, then retreated by 17.4% to $1.3 million in 2024, then jumped by 1706.76% to $22.7 million in 2025, then plunged by 71.74% to $6.4 million in 2026.
- According to Business Quant data, Other financing activities over the past three periods registered $6.4 million, $12.7 million, and $22.7 million for Q2 2026, Q1 2026, and Q4 2025 respectively.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Iqvia Holdings | 44.72 Bn | 42.64 Bn | 1.44 Bn |
| 2 | Medpace Holdings | 17.37 Bn | 16.87 Bn | 201.64 Mn |
| 3 | Icon | 13.65 Bn | 12.72 Bn | 479.29 Mn |
| 4 | Charles River Laboratories International | 13.13 Bn | 12.94 Bn | 452.07 Mn |
| 5 | Fortrea Holdings | 1.89 Bn | 1.72 Bn | 139.20 Mn |
| 6 | Evotec SE | 574.75 Mn | 148.87 Mn | - |
| 7 | Ginkgo Bioworks Holdings | 439.63 Mn | 355.09 Mn | 18.44 Mn |
| 8 | Champions Oncology | 69.43 Mn | 65.03 Mn | 7.70 Mn |
| 9 | MindWalk Holdings | 51.76 Mn | 46.29 Mn | 1.61 Mn |
| 10 | VivoSim Labs | 1.37 Mn | 1.37 Mn | - |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 6.42 Mn |
| Mar 31, 2026 | 12.67 Mn |
| Dec 31, 2025 | 22.73 Mn |
| Sep 30, 2025 | 7.99 Mn |
| Jun 30, 2025 | 351,000.00 |
| Mar 31, 2025 | 25.93 Mn |
| Dec 31, 2024 | 1.26 Mn |
| Sep 30, 2024 | 6.27 Mn |
| Jun 30, 2024 | 666,000.00 |
| Mar 31, 2024 | 7.66 Mn |
| Dec 31, 2023 | 1.52 Mn |
| Sep 30, 2023 | 5.73 Mn |
| Jun 30, 2023 | 1.66 Mn |
| Mar 31, 2023 | 2.46 Mn |
| Dec 31, 2022 | 5.76 Mn |
| Sep 30, 2022 | 892,000.00 |
| Jun 30, 2022 | 1.55 Mn |
| Mar 31, 2022 | 13.87 Mn |
| Dec 31, 2021 | 2.43 Mn |
| Sep 30, 2021 | 1.01 Mn |